The next generation of the supportive care needs survey: a brief screening tool for administration in the clinical oncology setting
The next generation of the supportive care needs survey: a brief screening tool for administration in the clinical oncology setting
复制标题
DOI：
10.1002/pon.1973
复制
发表时间：
2012-08-01
期刊：
影响因子：
3.6
通讯作者：
Lecathelinais, Christophe
中科院分区：
文献类型：
--
作者：
Girgis, Afaf;Stojanovski, Elizabeth;Lecathelinais, Christophe
目的：支持性护理需求调查（SCNS-SF 34）是一个34项的工具，用于评估被诊断患有癌症的人的感知需求。本研究旨在开发一种用于临床环境中患者的简短筛选工具，通过确定最小数量和最佳项目组合来测量具有高灵敏度和特异性的SCNS-SF 34结构域。研究方法：对澳大利亚12个主要公共癌症治疗中心的1458例患者的数据进行了二次分析;随机抽取67%（n = 977）的患者记录作为开发筛选工具的开发样本，而其余33%（n = 481）构成了重复分析的验证样本。应用五个标准来确定筛选工具的最佳项目子集。如果候选项目之间的统计结果非常相似，则选择被认为具有更重要临床意义的项目。结果：共筛选出9个条目，可作为SCNS-ST 9简易筛查工具。对SCNS-ST 9和原始SCNS-SF 34结果的总体比较表明，在SCNS-SF 34任何领域报告至少一个中度/高度需求的人中，只有11%的人因对SCNS-ST 9有中度/高度需求而被遗漏。结论：我们非常简单的筛查工具可以在临床环境中实施，以可靠地筛查癌症患者中未满足的需求，节省大量时间和费用，增加其在临床环境中广泛采用的潜力。版权所有（c）2011约翰威利父子有限公司
Objective: The short form of the Supportive Care Needs Survey (SCNS-SF34) is a 34-item instrument for assessing the perceived needs of people diagnosed with cancer. This research is aimed at developing a brief screening tool for administration to patients in the clinical setting, by identifying the minimum number and optimal combination of item(s) to measure each of the SCNS-SF34 domains with high sensitivity and specificity. Methods: Secondary analyses were undertaken on data from 1458 patients at 12 major public cancer treatment centres in Australia; with a random sample of 67% (n = 977) of the patient records selected as the developmental sample for developing the screening tool, while the remaining 33% (n = 481) constituted the validation sample on which analyses were repeated. Five criteria were applied to identify the optimum subset of items for the screening tool. Where statistical results were very similar across candidate item/s, items deemed more clinically important were chosen. Results: Nine items were identified, which can be efficiently and reliably used as a brief screening tool (SCNS-ST9). An overall comparison of the results on the SCNS-ST9 with the original SCNS-SF34 indicates that only 11% of people reporting at least one moderate/high need on any SCNS-SF34 domain were missed as having a moderate/high need on the SCNS-ST9. Conclusions: Our very brief screening tool can be implemented in a clinical setting to reliably screen for unmet needs among cancer patients, with considerable savings in time and expense, increasing its potential for wide-scale adoption in clinical settings. Copyright (c) 2011 John Wiley & Sons, Ltd.